UPEXI, INC. Files 8-K with Other Events and Exhibits
Ticker: UPXI · Form: 8-K · Filed: Nov 28, 2025 · CIK: 1775194
| Field | Detail |
|---|---|
| Company | Upexi, Inc. (UPXI) |
| Form Type | 8-K |
| Filed Date | Nov 28, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.00001, $3, $4 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, filing, corporate-update
TL;DR
UPEXI filed an 8-K on Nov 26, 2025, reporting other events and financials. Nothing major yet.
AI Summary
UPEXI, INC. filed an 8-K on November 28, 2025, reporting other events and financial statements and exhibits. The filing date was November 28, 2025, with the earliest event reported on November 26, 2025. The company, formerly known as GROVE, INC. until April 29, 2019, is incorporated in Delaware and headquartered in Tampa, Florida.
Why It Matters
This 8-K filing indicates UPEXI, INC. is providing updates on its corporate activities and financial reporting, which is crucial for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for other events and exhibits, not indicating any immediate significant financial or operational changes.
Key Players & Entities
- UPEXI, INC. (company) — Registrant
- GROVE, INC. (company) — Former Company Name
- November 26, 2025 (date) — Earliest Event Reported
- November 28, 2025 (date) — Filing Date
- Delaware (jurisdiction) — State of Incorporation
- Tampa, FL (location) — Principal Executive Offices
FAQ
What specific 'Other Events' are being reported by UPEXI, INC. in this 8-K filing?
The filing indicates 'Other Events' as an item information, but the specific details of these events are not provided in the excerpt.
When was UPEXI, INC. formerly known as GROVE, INC.?
UPEXI, INC. was formerly known as GROVE, INC. until April 29, 2019.
What is the principal executive office address for UPEXI, INC.?
The principal executive office address for UPEXI, INC. is 3030 N. Rocky Point Drive, Suite 420, Tampa, FL 33607.
What is the Commission File Number for UPEXI, INC.?
The Commission File Number for UPEXI, INC. is 001-40535.
What is the fiscal year end for UPEXI, INC.?
The fiscal year end for UPEXI, INC. is June 30.
Filing Stats: 611 words · 2 min read · ~2 pages · Grade level 9.9 · Accepted 2025-11-28 16:01:29
Key Financial Figures
- $0.00001 — ich registered Common Stock, par value $0.00001 UPXI NASDAQ Indicate by check mar
- $3 — n stock at a combined purchase price of $3.04, in a private placement offering pri
- $4 — warrants will have an exercise price of $4.00, will be immediately exercisable, an
Filing Documents
- upxi_8k.htm (8-K) — 25KB
- upxi_ex991.htm (EX-99.1) — 12KB
- 0001477932-25-008662.txt ( ) — 157KB
- upxi-20251126.xsd (EX-101.SCH) — 5KB
- upxi-20251126_lab.xml (EX-101.LAB) — 15KB
- upxi-20251126_cal.xml (EX-101.CAL) — 1KB
- upxi-20251126_pre.xml (EX-101.PRE) — 9KB
- upxi-20251126_def.xml (EX-101.DEF) — 2KB
- upxi_8k_htm.xml (XML) — 4KB
01 Other Events
Item 8.01 Other Events. On November 26, 2025, Upexi, Inc. (the "Company") issued a press release announcing that it had entered a securities purchase agreement with a single institutional investor, for the purchase and sale of 3,289,474 shares of common stock and warrants to purchase up to 3,289,474 shares of common stock at a combined purchase price of $3.04, in a private placement offering priced above the at-the-market price under Nasdaq Stock Market LLC rules. The warrants will have an exercise price of $4.00, will be immediately exercisable, and will expire 48 months from issuance. The closing of the Offering is expected to occur on or about December 1, 2025, subject to the satisfaction of customary closing conditions. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein. The information in Item 8.01, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be deemed incorporated by reference in any of the Company's filings under the Securities Act, or the Exchange Act, whether made before or after the date hereof, except as shall be expressly set forth by specific reference to this Report in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Exhibit Description 99.1 Press Release of Upexi, Inc., dated November 26, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL Document) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. UPEXI, INC. Dated: November 28, 2025 /s/ Andrew J. Norstrud Name: Andrew J. Norstrud Title: Chief Financial Officer 3